Sign in
Taking people in United StatesNo phase

Personalized Brain Stimulation to Help Veterans Quit Smoking

Key facts

Who runs it
VA Office of Research and Development
Where
Charleston, United StatesSee the site
Trial code
Status
Recruiting
People taking part
56 people, planned
Started
1 Jul 2026
Expected to end
31 Aug 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Transcranial Magnetic Stimulation
  • Personalized-image-guided and E-field-modeling dose rTMS (precision TMS)
Record updated
4 August 2026

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Veteran
  • Individuals who smoke 10 or more cigarettes per day and have a CO level > 10 ppm indicative of recent smoking
  • Those who have not received substance abuse treatment within the previous 30 days
  • Those who have been stable on psychotropic medications for at least three months
  • For females, those who test non-pregnant and use adequate birth control
  • Those who are willing to provide informed consent
  • Those who can comply with protocol requirements and likely complete all study procedures
  • Those who are motivated to quit smoking (based on responses of "very likely" or "somewhat likely" in the motivation questionnaire

Who cannot take part

  • Contraindications to rTMS (history of a seizure or epilepsy)
  • A history of autoimmune, endocrine, viral, or vascular disorders affecting the brain
  • History or MRI evidence of neurological disorder that would lead to local or diffuse brain lesions or significant physical impairment
  • Unstable cardiac disease, uncontrolled hypertension, severe renal or liver insufficiency, or sleep apnea
  • Major Axis I disorders diagnosed according to DSM-V criteria, such as bipolar affective disorder, schizophrenia, dementia, or major depression; Regarding the Veteran population, the investigators will enroll smokers who have PTSD
  • Current moderate to severe substance use of any psychoactive substances other than nicotine or caffeine, as defined by DSM-V criteria
  • Contraindications to MRI (e.g., metal in the skull, orbital or intracranial cavity, or claustrophobia)
  • Current use of other forms of nicotine delivery, such as nicotine patches or electronic cigarettes
  • Currently prescribed bupropion and/or varenicline

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

This trial is currently available in United States.

  • Ralph H. Johnson VA Medical Center, Charleston, SCCharleston, United StatesContact: R. Amanda C LaRue, PhDTaking people

About the trial

What the trial wants to find out

Cigarette smoking is a significant public health concern for Veterans. Encouraging smoking cessation continues to be a top priority for the Veterans' Administration as Veterans who use tobacco experience negative health effects, including cancer, heart disease, and mental disorders. Despite the efficacy of current evidence-based pharmacotherapies and psychotherapies for smoking cessation, alternative treatments are critically needed. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive form of brain stimulation, US FDA-approved for smoking cessation. In this protocol, the investigators propose comparing the two rTMS protocols (standard TMS vs. precision TMS) to find a better treatment parameter for smoking cessation in Veterans. Identifying an efficacious rTMS protocol would benefit Veterans who want to quit smoking.

The 2 groups in the trial

  • Deep rTMSExisting treatment, for comparison

    The first group will receive 10 Hz DTMS (standard TMS) with a protocol of 3 seconds on, 15 seconds off, and a total of 1800 pulses/session, lasting 18 minutes, targeting the bilateral insula and lateral prefrontal cortex.

    Treatment: Transcranial Magnetic Stimulation

  • Precision TMSTreatment being tested

    The other group will receive 10 Hz personalized-image-guided and Efield-modeling dose rTMS (precision TMS) with a protocol of 5 seconds on, 10 seconds off, and a total of 3000 pulses/session, lasting 15 minutes, targeting the left dorsolateral prefrontal cortex (DLPFC).

    Treatment: Personalized-image-guided and E-field-modeling dose rTMS (precision TMS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Circuity-guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Tobacco Use in Veterans: A Comparison of Insula-rTMS and Prefrontal-rTMS
Criteria questions
Built from NCT07050862, who can take part
Record updated
4 August 2026